Search

Subject Drug development -- Periodicals

6161. Xanthine oxidase activity in thiopurine curative Chinese inflammatory bowel disease patients. Issue 3 (30th April 2021)

Authors:
Ding, Liang; Zhang, Fang‐bin; Liu, Hui; Gao, Xiang; Bi, Hui‐chang; Huang, Ling; Wang, Xue‐ding; Chen, Bai‐li; Zhang, Yu; Lv, Chuanzhu; Hu, Pin‐jin; Huang, Min
Journal:
Pharmacology research & perspectives
Issue:
Volume 9:Issue 3(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6162. XG‐102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double‐blind, placebo‐controlled, dose‐escalating study. Issue 1 (26th January 2014)

Authors:
Deloche, Catherine; Lopez‐Lazaro, Luis; Mouz, Sébastien; Perino, Julien; Abadie, Claire; Combette, Jean‐Marc
Journal:
Pharmacology research & perspectives
Issue:
Volume 2:Issue 1(2014:Feb.)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6163. XG‐102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double‐blind, placebo‐controlled, dose‐escalating study. Issue 1 (26th January 2014)

Authors:
Deloche, Catherine; Lopez‐Lazaro, Luis; Mouz, Sébastien; Perino, Julien; Abadie, Claire; Combette, Jean‐Marc
Journal:
Pharmacology research & perspectives
Issue:
Volume 2:Issue 1(2014:Feb.)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6167. ZPI prevents ox‐LDL‐mediated endothelial injury leading to inhibition of EndMT, inflammation, apoptosis, and oxidative stress through activating Pi3k/Akt signal pathway. Issue 5 (2nd June 2022)

Authors:
Zhang, Xingxu; Li, Zhiqiang; Liu, Xiangdong; Qin, Xiaoming; Luo, Jiachen; Zhang, Wenming; Liu, Baoxin; Wei, Yidong
Journal:
Drug development research
Issue:
Volume 83:Issue 5(2022)
Page Start:
1212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6168. ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer. Issue 4 (13th August 2020)

Authors:
Ghoshdastidar, Krishnarup; Patel, Hoshang; Bhayani, Hitesh; Patel, Ankit; Thakkar, Kinjal; Patel, Dinesh; Sharma, Manoranjan; Singh, Jaideep; Mohapatra, Jogeswar; Chatterjee, Abhijit; Patel, Dipam; Bahekar, Rajesh; Sharma, Rajiv; Gupta, Lakshmikant; Patel, Nirmal; Giri, Poonam; Srinivas, Nuggehal...
Journal:
Pharmacology research & perspectives
Issue:
Volume 8:Issue 4(2020)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6169. Α1D‐Adrenoceptors are responsible for the high sensitivity and the slow time‐course of noradrenaline‐mediated contraction in conductance arteries. Issue 1 (28th August 2013)

Authors:
Flacco, Nicla; Parés, Jaime; Serna, Eva; Segura, Vanessa; Vicente, Diana; Pérez‐Aso, Miguel; Noguera, María Antonia; Ivorra, María Dolores; McGrath, John C.; D'Ocon, Pilar
Journal:
Pharmacology research & perspectives
Issue:
Volume 1:Issue 1(2013:Oct.)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗